EXHIBIT 99.2

WebMD CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data, unaudited)

			Three Months Ended						Nine Months Ended
			September 30,						September 30,
			2003			2002			2003			2002
Revenue			$	250,635		$	217,004		$	705,584		$	642,220
Costs and expenses:
		Cost of operations		149,270			123,360			410,556			379,101
		Development and engineering		11,334			10,869			32,654			32,640
		Sales, marketing, general and administrative		72,450			66,883			209,917			218,501
		Depreciation, amortization and other		11,097			32,073			52,961			95,575
		Legal expense		493			—			493			—
		Restructuring and integration benefit		—			2,100			—			5,850
		Gain on investments		3,039			681			3,222			6,547
		Interest income		6,401			5,222			16,434			14,341
		Interest expense		4,703			2,819			10,444			5,677
		Other income		—			2,323			1,118			2,323
Income (loss) from continuing operations before income tax provision (benefit)				10,728			(8,674	)		9,333			(60,213	)
		Income tax provision (benefit)		1,273			(12,103	)		3,261			(10,700	)
Income (loss) from continuing operations				9,455			3,429			6,072			(49,513	)
Income (loss) from discontinued operations, net of income taxes				(3,366	)		1,109			(33,611	)		2,240
Net income (loss)			$	6,089		$	4,538		$	(27,539	)	$	(47,273	)
Basic income (loss) per common share:
		Income (loss) from continuing operations	$	0.03		$	0.01		$	0.02		$	(0.16	)
		Income (loss) from discontinued operations		(0.01	)		0.01			(0.11	)		0.01
Net income (loss)			$	0.02		$	0.02		$	(0.09	)	$	(0.15	)
Diluted income (loss) per common share:
		Income (loss) from continuing operations	$	0.03		$	0.01		$	0.02		$	(0.16	)
		Income (loss) from discontinued operations		(0.01	)		0.00			(0.10	)		0.01
Net income (loss)			$	0.02		$	0.01		$	(0.08	)	$	(0.15	)
Weighted-average shares outstanding used in computing income (loss) per common share:
	Basic			305,471			297,352			304,121			306,161
	Diluted			328,463			308,537			326,396			306,161

WebMD CORPORATION
CONSOLIDATED SEGMENT INFORMATION
(In thousands, except per share data, unaudited)

		Three Months Ended						Nine Months Ended
		September 30,						September 30,
		2003			2002			2003			2002
Revenues
	Transaction services	$	131,977		$	115,026		$	365,491		$	350,157
	Physician services		75,487			70,581			224,295			202,738
	Portal services		31,164			19,851			79,882			54,991
	Plastic technologies (a)		19,093			16,803			55,015			49,552
	Inter-segment eliminations		(7,086	)		(5,257	)		(19,099	)		(15,218	)
		$	250,635		$	217,004		$	705,584		$	642,220
Income (loss) before restructuring, taxes, non-cash and other items
	Transaction services	$	21,767		$	24,327		$	68,160		$	60,129
	Physician services		3,686			7,174			16,342			19,660
	Portal services		8,712			3,577			18,922			(3,479	)
	Plastic technologies (a)		5,690			5,125			15,857			15,526
	Corporate		(12,809	)		(11,493	)		(37,652	)		(38,741	)
	Interest income		6,401			5,222			16,434			14,341
	Interest expense		(4,703	)		(2,819	)		(10,444	)		(5,677	)
			28,744			31,113			87,619			61,759
	Basic income per common share before restructuring, taxes, non-cash and other items (b)	$	0.09		$	0.10		$	0.29		$	0.20
	Diluted income per common share before restructuring, taxes, non-cash and other items (b)	$	0.09		$	0.10		$	0.27		$	0.20
Restructuring, taxes, non-cash and other items (c)
	Depreciation, amortization and other		(11,097	)		(32,073	)		(52,961	)		(95,575	)
	Amortization of prepaid content and services (included in cost of operations)		(1,105	)		(453	)		(1,932	)		(2,176	)
	Amortization of prepaid content and services (included in sales, marketing, general and administrative)		(4,970	)		(5,696	)		(16,292	)		(17,382	)
	Non-cash stock compensation (included in sales, marketing, general and administrative)		(3,390	)		(6,669	)		(10,948	)		(21,559	)
	Restructuring and integration benefit		—			2,100			—			5,850
	Legal expense		(493	)		—			(493	)		—
	Gain on investments		3,039			681			3,222			6,547
	Income tax (provision) benefit		(1,273	)		12,103			(3,261	)		10,700
	Other income		—			2,323			1,118			2,323
Income (loss) from continuing operations			9,455			3,429			6,072			(49,513	)
Income (loss) from discontinued operations, net of income taxes			(3,366	)		1,109			(33,611	)		2,240
Net income (loss)		$	6,089		$	4,538		$	(27,539	)	$	(47,273	)
Basic income (loss) per common share:
	Income (loss) from continuing operations	$	0.03		$	0.01		$	0.02		$	(0.16	)
	Income (loss) from discontinued operations		(0.01	)		0.01			(0.11	)		0.01
Net income (loss)		$	0.02		$	0.02		$	(0.09	)	$	(0.15	)
Diluted income (loss) per common share:
	Income (loss) from continuing operations	$	0.03		$	0.01		$	0.02		$	(0.16	)
	Income (loss) from discontinued operations		(0.01	)		0.00			(0.10	)		0.01
Net income (loss)		$	0.02		$	0.01		$	(0.08	)	$	(0.15	)
Weighted-average shares outstanding used in computing income (loss) per common share:
	Basic		305,471			297,352			304,121			306,161
	Diluted		328,463			308,537			326,396			306,161

(a)	Effective August 1, 2003, the Company completed the sale of two operating units of its Plastic Technologies segment, Porex Bio Products, Inc. and Porex Medical Products, Inc., in two separate transactions. Beginning in the quarter ended September 30, 2003, the Company’s consolidated financial statements reflect these operating units as discontinued operations for all prior periods. The above segment information reflects these operating units as discontinued operations for the current and prior periods.
(b)	Basic and diluted income (loss) per common share before restructuring, taxes, non-cash and other items is based on the weighted-average shares outstanding used in computing basic and diluted income (loss) per common share.
(c)	Reconciliation of income (loss) before restructuring, taxes, non-cash and other items to income (loss) from continuing operations.

WebMD CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)

			September 30,		December 31,
			2003		2002
			(Unaudited)
Assets
Cash and cash equivalents			$	83,872	$	175,596
Short-term investments				211,378		10,888
Accounts receivable, net				172,988		163,244
Inventory				11,120		9,976
Current portion of prepaid content and distribution services				23,582		25,406
Assets of discontinued operations				—		94,056
Other current assets				23,810		25,814
		Total current assets		526,750		504,980
Marketable debt securities				678,315		449,289
Marketable equity securities				5,681		7,427
Property and equipment, net				80,264		70,488
Prepaid content and distribution services				32,670		48,532
Goodwill				667,444		586,043
Intangible assets, net				91,806		73,222
Other assets				34,733		26,267
			$	2,117,663	$	1,766,248
Liabilities and Stockholders’ Equity
Accounts payable			$	10,389	$	10,063
Accrued expenses				217,479		208,342
Deferred revenue				83,959		81,179
Liabilities of discontinued operations				—		12,365
	Total current liabilities			311,827		311,949
Convertible subordinated notes				649,999		300,000
Other long-term liabilities				1,338		498
Stockholders’ equity				1,154,499		1,153,801
			$	2,117,663	$	1,766,248

WebMD CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)

					Nine Months Ended
					September 30,
					2003			2002
Cash flows from operating activities:
Net loss					$	(27,539	)	$	(47,273	)
Adjustments to reconcile net loss to net cash provided by operating activities:
		(Income) loss from discontinued operations				33,611			(2,240	)
		Depreciation, amortization and other				52,961			95,575
		Amortization of debt issuance costs				1,505			740
		Non-cash content and distribution services				18,224			19,558
		Non-cash stock based compensation				10,948			21,559
		Gain on investments				(3,222	)		(6,547	)
		Changes in operating assets and liabilities:
			Accounts receivable			3,580			5,226
			Inventory			(1,144	)		711
			Federal income tax receivable			—			(12,887	)
			Prepaid content and distribution services			(537	)		(201	)
			Accounts payable			(775	)		(3,220	)
			Accrued expenses			(12,174	)		(10,216	)
			Deferred revenue			(2,228	)		6,822
			Other, net			5,685			(8,001	)
				Net cash provided by continuing operations		78,895			59,606
				Net cash provided by discontinued operations		5,130			5,809
				Net cash provided by operating activities		84,025			65,415
Cash flows from investing activities:
	Proceeds from maturities and sales of available-for-sale securities					11,322			106,108
	Proceeds from maturities and redemptions of held-to-maturity securities					157,919			59,095
	Purchases of available-for-sale securities					(7,754	)		(206,983	)
	Purchases of held-to-maturity securities					(590,113	)		(300,970	)
	Purchases of property and equipment					(13,643	)		(20,737	)
	Proceeds received from sale of discontinued operations					46,500			—
	Cash paid in business combinations, net of cash acquired					(133,471	)		(9,929	)
	Other changes in equity of discontinued operations					1,754			7,511
				Net cash used in continuing operations		(527,486	)		(365,905	)
				Net cash used in discontinued operations		(2,529	)		(9,184	)
				Net cash used in investing activities		(530,015	)		(375,089	)
Cash flows from financing activities:
	Proceeds from issuance of common stock					35,367			14,313
	Payments of notes payable and other					(211	)		(2,899	)
	Redemption of Series B Preferred Stock					—			(10,000	)
	Purchases of treasury shares					(18,125	)		(103,784	)
	Net proceeds from issuance of convertible debt					339,125			292,000
				Net cash provided by continuing operations		356,156			189,630
				Net cash used in discontinued operations		(6,546	)		(1,147	)
				Net cash provided by financing activities		349,610			188,483
Effect of exchange rates on cash						711			765
Net decrease in cash and cash equivalents						(95,669	)		(120,426	)
Changes in cash attributable to discontinued operations						3,945			4,522
Cash and cash equivalents at beginning of period						175,596			278,513
Cash and cash equivalents at end of period					$	83,872		$	162,609